Preoperative predictive factors and further risk stratification of biochemical recurrence in clinically localized high-risk prostate cancer

被引：0
|
作者：
Riu Hamada
Jun Nakashima
Makoto Ohori
Yoshio Ohno
Osamu Komori
Kunihiro Yoshioka
Masaaki Tachibana
机构：
[1] Tokyo Medical University,Department of Urology, Tokyo Medical University Hospital
[2] The Institute of Statistical Mathematics,Department of Mathematical Analysis and Statistical Inference
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Radical prostatectomy; High-risk prostate cancer; PSA density; PSA density of the transition zone; Percentage of positive cores from the dominant side; Biochemical recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：595 / 600
页数：5
相关论文
共 50 条
  • [41] Contemporary management of high-risk localized prostate cancer
    Garzotto M.
    Hung A.Y.
    [J]. Current Urology Reports, 2010, 11 (3) : 159 - 164
  • [42] Surgical management of high-risk, localized prostate cancer
    Wilkins, Lamont J.
    Tosoian, Jeffrey J.
    Sundi, Debasish
    Ross, Ashley E.
    Grimberg, Dominic
    Klein, Eric A.
    Chapin, Brian F.
    Nyame, Yaw A.
    [J]. NATURE REVIEWS UROLOGY, 2020, 17 (12) : 679 - 690
  • [43] Localized intermediate- to high-risk prostate cancer
    Tritschler, S.
    Ganswindt, U.
    Stief, C. G.
    [J]. UROLOGE, 2016, 55 (03): : 318 - +
  • [44] Systemic treatments for high-risk localized prostate cancer
    Pignot, Geraldine
    Maillet, Denis
    Gross, Emmanuel
    Barthelemy, Philippe
    Beauval, Jean-Baptiste
    Constans-Schlurmann, Friederike
    Loriot, Yohann
    Ploussard, Guillaume
    Sargos, Paul
    Timsit, Marc-Olivier
    Vincendeau, Sebastien
    Pasticier, Gilles
    Borchiellini, Delphine
    [J]. NATURE REVIEWS UROLOGY, 2018, 15 (08) : 498 - 510
  • [45] Optimizing the Management of High-Risk, Localized Prostate Cancer
    Sundi, Debasish
    Jeong, Byong Chang
    Lee, Seung Bae
    Han, Misop
    [J]. KOREAN JOURNAL OF UROLOGY, 2012, 53 (12) : 815 - 820
  • [46] Surgical management of high-risk, localized prostate cancer
    Lamont J. Wilkins
    Jeffrey J. Tosoian
    Debasish Sundi
    Ashley E. Ross
    Dominic Grimberg
    Eric A. Klein
    Brian F. Chapin
    Yaw A. Nyame
    [J]. Nature Reviews Urology, 2020, 17 : 679 - 690
  • [47] High-risk localized prostate cancer: Integrating chemotherapy
    Oh, WK
    [J]. ONCOLOGIST, 2005, 10 : 18 - 22
  • [48] Neoadjuvant therapy for high-risk localized prostate cancer
    Evan Y. Yu
    William K. Oh
    [J]. Current Oncology Reports, 2003, 5 (3) : 250 - 257
  • [49] Systemic treatments for high-risk localized prostate cancer
    Géraldine Pignot
    Denis Maillet
    Emmanuel Gross
    Philippe Barthelemy
    Jean-Baptiste Beauval
    Friederike Constans-Schlurmann
    Yohann Loriot
    Guillaume Ploussard
    Paul Sargos
    Marc-Olivier Timsit
    Sébastien Vincendeau
    Gilles Pasticier
    Delphine Borchiellini
    [J]. Nature Reviews Urology, 2018, 15 : 498 - 510
  • [50] The importance of surgical margins for biochemical recurrence in high-risk prostate cancer patients.
    Srougi, Victor
    Sanchez-Salas, Rafael
    Secin, Fernando P.
    Nunes-Silva, Igor
    Baghdadi, Mohammed
    Barreras, Silvia Garcia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345